Attovia IPO

Pipeline of bio-therapeutics with an initial focus on immune-mediated diseases.

NASDAQ: ATTO

Buy

Buy Private Stock

Sign up to invest in private companies like Attovia before their IPO.

Sell

Sell Private Stock

Sign up to sell private companies like Attovia before their IPO.

Overview

Attovia completed their IPO on August 5, 2026. Now that Attovia is a public company, Nasdaq Private Market does not actively track its performance. The data below is for reference before the company’s IPO.

Attovia is creating a pipeline of biotherapeutics with an initial focus on immune-mediated disease and oncology. We leverage ATTOBODY, a novel biologics platform, to generate small format biparatopic binders that unlock the spatial aspect of target engagement.

Sector

Healthcare & Life Sciences

Founded

2022

Headquarters

Fremont, CA

Attovia Funding

Attovia Funding History Pre-IPO

Gain insights into Attovia funding history prior to their IPO, including the funding round, time period, and amount raised.

Financing Round Date Amount Price per share Valuation
Round Date Amount PPS Valuation
Series C Apr 15, 2025 90M
XXXXX
XXXXX
Series B May 09, 2024 53M
XXXXX
XXXXX
Series B May 01, 2024 52M
XXXXX
XXXXX
Series A Jan 18, 2024 30M
XXXXX
XXXXX
Series A Jun 01, 2023 30M
XXXXX
XXXXX

Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market

Buy

Buy Private Stock

Sign up to invest in private companies like Attovia before their IPO.

Sell

Sell Private Stock

Sign up to sell private companies like Attovia before their IPO.

Attovia Management Team

Attovia people and management – Prior to IPO

  • Chief Business Officer
    Zanetta Odrowaz
  • Chief Scientific Officer
    Petter Veiby
  • Board Member
    Jamie Topper
  • Chief Technology Officer
    Hangjun Zhan
  • Board Member
    Colin Walsh
  • Chief Medical Officer
    Hubert Chen
  • Board Member
    Aaron Royston
  • Board Member
    Mitchell Gold
  • Chief Financial Officer
    Steven Chan
  • Board Member
    Angie You
  • Co-Founder, CEO, Board Member
    Tao Fu
  • Co-Founder, Board Member
    Yuling Luo

Investors

Major Attovia investors

  • venBio Partners

  • Marshall Wace

  • EcoR1 Capital

  • Nextech Ventures

  • Cormorant Asset Management

  • Logos Capital

  • Frazier Life Sciences Management

  • Redmile Group

  • Cormorant Capital

  • Illumina

  • Goldman Sachs & Co

Attovia Valuations & Financials

Looking for private company valuations and share price data?

Nasdaq Private Market Data & Intelligence is the private company valuation database covering 4,000+ venture-backed companies with daily pricing, financing history, and secondary market activity. View real-time NPM data on pre-IPO companies including valuations, private company comparable transactions, and historical share price information — the private company due diligence data sources institutional investors rely on.

Similar Companies

Explore companies

like Attovia

  • Cerebral

    Healthcare & Life Sciences

    Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.

  • Roman Health Ventures-Logo

    Ro

    Healthcare & Life Sciences

    Healthcare technology for a patient-centric healthcare system.

  • Somatus-Logo

    Somatus

    Healthcare & Life Sciences

    Integrated care for patients with or at risk of developing kidney disease.

  • Cityblock Health-Logo

    Cityblock

    Healthcare & Life Sciences

    Tech-driven care provider for communities with complex needs.

  • Benchling-Logo

    Benchling

    Healthcare & Life Sciences

    Cloud based platform for research and development in biotechnology.

  • Insitro-Logo

    insitro

    Healthcare & Life Sciences

    Drug discovery and development company.

  • Carrot Fertility-Logo

    Carrot Fertility

    Healthcare & Life Sciences

    Medical services including egg freezing and in vitro fertilization (IVF).

  • BillionToOne

    Healthcare & Life Sciences

    Developed a DNA molecular counting technology for detecting gene disorders through a blood test.

  • Nutcracker Therapeutics-Logo

    Nutcracker Therapeutics

    Healthcare & Life Sciences

    Develops RNA-based therapeutics using innovative manufacturing and synthesis platform to advance mRNA treatments and formulations.

FAQ

Questions?

We have answers

Buy Attovia Stock

Attovia became publicly traded following its IPO on August 5, 2026, its shares now trade on public stock exchanges under the ticker symbol NASDAQ: ATTO. Before the IPO, Attovia stock was privately held and available only through private market transactions.

If you’re an accredited investor looking to purchase pre-IPO shares in a private company, Nasdaq Private Market can help you get started. Learn more about investing in the private market or sign up for free to explore available opportunities. Learn more about how private company shares trade prior to an IPO on our investors page.

Sell Attovia Stock

Following its IPO on August 5, 2026, Attovia shares trade on public stock exchanges, allowing shareholders to sell stock through a traditional brokerage.

If you currently hold shares in a private company, Nasdaq Private Market may be able to help you explore your sell private company stock. Our platform provides a secure and compliant way to sell your shares on terms that work for both you and the company. To understand how employees sell shares before a company goes public, visit the Employee Shareholders page.

 

Attovia Stock Price

Following the IPO, Attovia stock prices can now be viewed publicly on major exchanges. Investors and interested parties can find the current stock price by searching Attovia’s ticker symbol on financial platforms such as Nasdaq.com or through their preferred brokerage platform.

Attovia Stock Ticker Symbol

Following its IPO on August 5, 2026, Attovia stock now trades on public markets under the ticker symbol NASDAQ: ATTO. You can view real-time stock information through widely used financial data platforms.

Criteria to Sell Attovia Stock

Following the Attovia IPO, public shares can be sold through any brokerage.

Nasdaq Private Market works with employees, ex-employees, and other private company shareholders of pre-IPO companies to sell their shares. The Nasdaq Private Market platform provides a secure and compliant way to sell your shares on terms that work for both you and the company. To learn more about how to sell private company stock, visit the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

 

Criteria to Buy or Invest in Attovia Stock

Following Attovia’s initial public offering on August 5, 2026, its shares are now listed on a public exchange and available for purchase through a brokerage account. Investors interested in buying Attovia stock can do so through their preferred broker, just as they would with any other publicly traded security.

Nasdaq Private Market continues to work with investors seeking exposure to private company opportunities prior to IPO. Through structured transactions and curated offerings, investors can participate in private market activity before companies enter the public markets.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Attovia Stock Settlement

Since Attovia is now publicly traded, public-market share transfers and settlement occur automatically through a brokerage or exchange.

Nasdaq Private Market supports transfer and settlement for privately held company equity. In order to buy or sell private company stock, share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patented Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Attovia IPO

Attovia completed its IPO on August 5, 2026, and is now publicly available through major financial sources.